SARS-CoV-2 antibody prevalence among healthcare workers: A cross-sectional study at a quaternary healthcare center in Saudi Arabia
Background: The objective of this study was to determine the seroprevalence of SARS-CoV-2 antibodies among Healthcare Workers (HCWs). Methods: We carried out a cross-sectional study among 3644 HCWs at King Saud Medical City (KSMC) during the last two weeks of December 2020. A Google form survey was...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_d39bcf94d9984dac9d7b646f41f45aca | ||
042 | |a dc | ||
100 | 1 | 0 | |a Hala A. Amer |e author |
700 | 1 | 0 | |a Hassan A. Abdallah |e author |
700 | 1 | 0 | |a Haifa S. Alkheledan |e author |
700 | 1 | 0 | |a Shaimaa H. Alzarzour |e author |
700 | 1 | 0 | |a Ahmad Shrahily |e author |
700 | 1 | 0 | |a Hani Tamim |e author |
700 | 1 | 0 | |a Saleh A. Alqahtani |e author |
700 | 1 | 0 | |a Ziad A. Memish |e author |
245 | 0 | 0 | |a SARS-CoV-2 antibody prevalence among healthcare workers: A cross-sectional study at a quaternary healthcare center in Saudi Arabia |
260 | |b Elsevier, |c 2022-03-01T00:00:00Z. | ||
500 | |a 1876-0341 | ||
500 | |a 10.1016/j.jiph.2022.01.018 | ||
520 | |a Background: The objective of this study was to determine the seroprevalence of SARS-CoV-2 antibodies among Healthcare Workers (HCWs). Methods: We carried out a cross-sectional study among 3644 HCWs at King Saud Medical City (KSMC) during the last two weeks of December 2020. A Google form survey was used to collect data on demographics, underlying health conditions, job duties, infection control competencies, COVID-19 exposure history, symptoms, and confirmed infections. Findings: 26.5% demonstrated seropositivity to SARS-CoV-2 antibodies, 10-fold higher than the national seroprevalence (2.36) conducted in May 2020. Seropositivity was significantly higher among non-Saudi HCWs and participants who lived outside the hospital dormitory p < 0.0001 and 0.01, respectively). Seropositivity was significantly higher among HCWs who worked on clinical areas of high exposure level, and those who spent longer duration working with patients with COVID-19; p = 0.002 and 0.005, respectively). Conclusion: SARS-CoV-2 infections among HCWs can go unrecognized, which magnifies the importance of complying with universal masking and social distancing directives. Detecting SARS-CoV-2 antibodies in HCWs can help healthcare leaders in considering staff allocations and assignments accordingly. | ||
546 | |a EN | ||
690 | |a COVID-19 | ||
690 | |a SARS-CoV-2 antibodies | ||
690 | |a Healthcare workers | ||
690 | |a Infection Control measures | ||
690 | |a Saudi Arabia | ||
690 | |a Infectious and parasitic diseases | ||
690 | |a RC109-216 | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Infection and Public Health, Vol 15, Iss 3, Pp 343-348 (2022) | |
787 | 0 | |n http://www.sciencedirect.com/science/article/pii/S1876034122000302 | |
787 | 0 | |n https://doaj.org/toc/1876-0341 | |
856 | 4 | 1 | |u https://doaj.org/article/d39bcf94d9984dac9d7b646f41f45aca |z Connect to this object online. |